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ABSTRACT 
 Normal folate, homocysteine, and methyl group metabolism is critical for maintaining 
optimum health, and perturbations in these mechanisms may lead to a number of pathological 
conditions such as diabetes, cardiovascular disease, neural tube defects, and cancer. 
Hyperhomocysteinemia is a condition that occurs when blood plasma concentrations of 
homocysteine exceed 15μM and has been implicated as an independent risk factor in 
cardiovascular disease. Specifically, populations with genetic polymorphisms in folate-
dependent remethylation or poor B-vitamin status are at risk for this condition. This study 
was conducted in order to determine the influence of exercise on homocysteine and methyl 
group metabolism in a folate-deficient and -sufficient mouse model. Elevated homocysteine 
concentrations observed in the folate-deficient sedentary group were reduced by more than 2-
fold with the addition of both forced treadmill and free access wheel exercise (p < 0.001).  
Similar results were observed in the folate-sufficient control diet with treadmill and wheel 
exercised mice having about 50% lower homocysteine concentrations than their sedentary 
counterparts (p < 0.001). Increased renal homocysteine remethylation through the enzyme 
betaine-homocysteine S-methyltransferase (BHMT) was observed in wheel exercised mice 
suggesting an increasingly important role in kidney homocysteine metabolism with exercise 
(p < 0.05).  To our knowledge, this is the first study showing the attenuation of 
hyperhomocysteinemia in a model known to experience perturbed homocysteine metabolism. 
Findings from this study will be useful in determining the influence exercise has in other 
populations of altered homocysteine metabolism such as diabetics, vegans, and individuals 
with genetic polymorphisms.   
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CHAPTER 1 – GENERAL INTRODUCTION 
Thesis Organization 
 This thesis is divided into four chapters including a general introduction, review of 
the literature, manuscript prepared for publication, and general conclusions. Chapter 1 
includes an introduction on the significance of research in this area with a description of 
research questions. An extensive review of the literature will be found in Chapter 2 exploring 
folate, methyl group, and homocysteine metabolism and the importance of those mechanisms 
in the author’s original research. Chapter 3 will explain the impact exercise has on 
homocysteine and methyl group metabolism in a folate-deficient mouse model. General 
conclusions including ideas for future research will be included in Chapter 4 and a list of 
cited literature used throughout the thesis will be included at the end.  
Description of the Research Questions 
 Folate, methyl group, and homocysteine metabolism are interrelated mechanisms that 
are required in a number of cellular processes including methylation of nucleic acids, 
proteins, and lipids. Perturbations in these pathways have been implicated in a number of 
disease states such as cardiovascular disease, diabetes, cancer, and neural tube defects. The 
search for therapeutic techniques aimed at normalizing these interconnected pathways is a 
major reason for conducting the present study. 
 The current literature regarding the influence of exercise on homocysteine, methyl 
group, and homocysteine metabolism is fairly controversial with a number of studies 
claiming an increase in homocysteine with exercise whereas others found a decrease or no 
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change at all (1-9). Moreover, most studies utilize the human model, which limits the use of 
invasive techniques for analyzing pertinent enzymes associated with methyl group and 
homocysteine metabolism in tissues such as the liver and kidney. Moreover, poor dietary 
records, such as ignoring B-vitamin status, and a variety of exercise modes among studies 
make it difficult to draw definitive conclusions. Therefore, we chose to utilize a folate-
deficient mouse model, which possess a dietary status previously shown to display 
characteristics of hyperhomocysteinemia, so we could monitor food intake and exercise 
patterns (10, 11). In addition to collecting blood plasma for homocysteine concentration 
determination, we would also be able to further analyze enzymes important to homocysteine 
metabolism in both the liver and kidney.  
 The benefit of exercise is well established in the literature specifically with its 
favorable effects on the cardiovascular system; however, specific mechanisms regarding the 
benefits of exercise are not entirely clear (12, 13). Although controversial, 
hyperhomocysteinemia has been moderately accepted as an independent risk factor for 
cardiovascular disease and thus warrants further investigation concerning mechanisms to 
reduce homocysteine concentrations (14). The mouse model for this study is representative 
of populations prone to elevated homocysteine concentrations including individuals with 
genetic polymorphisms, such as in the enzyme methylenetetrahydrofolate reductase 
(MTHFR), vegans with poor vitamin status, and diabetics. Therefore, the goal of this study 
was to determine the influence of exercise on homocysteine metabolism in a folate-deficient 
mouse model. Results from this study can be further utilized in establishing the impact of 
exercise on other animal models of hyperhomocysteinemia.   
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CHAPTER 2 – REVIEW OF THE LITERATURE 
Folate Structure and Function 
 Folate, a generic term used for the collection of folic acid derivatives and also 
referred to as vitamin B9, is required for a number of essential biochemical reactions in 
metabolism to sustain life (15).  The physical structure of folate contains 3 main components, 
including a pterin ring, a p-aminobenzoic acid moiety, and a polyglutamate chain ranging 
from 1 to 14 glutamate amino acids (Figure 2.1) (15, 16). Complete reduction of the 
pyrazine ring of the pterin constituent renders the folic acid molecule into its coenzymatically 
active tertrahydro form, known as tetrahydrofolate (THF), allowing for the addition of 1 
carbon moieties at the N-5 and/or N-10 position for a number of biological reactions known 
as one-carbon metabolism (16, 17). Major sources of methyl groups available for THF 
activation within the cell are derived from formate, serine, histidine, and purines (18). 
Moreover, compartmentalization among the cytosol, nucleus, and mitrochondria within the 
Figure 2.1: Basic structure of the folate molecule (modified from 43) 
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cell allows for strict control of one-carbon metabolism (18).  One carbon units exist in many 
oxidation states ranging from the most reduced methyl group to the most oxidized formimino 
group, which will dictate its function within the cell (Figure 2.2) (15, 16).  
 As a vitamin and cofactor for numerous enzymes, folate must be acquired through the 
diet as humans are unable to synthesize it. However, gut bacteria can synthesize folate, which 
contributes to folate availability in the body (19). Polyglutamate forms of folate attained 
through the diet must be hydrolyzed into monoglutamate forms via folate hydrolase enzymes 
for absorption across the intestinal mucosa (16). Moreover, a folate-deficient state 
upregulates hydrolase enzymes to promote and enhance intestinal absorption (16). 
Unfortunately, the bioavailability of folate from natural food sources is low due to the high 
levels of polyglutamate folate. This decrease in bioavailability may be due to evolutionary 
factors to limit folate concentrations in the body. However, folic acid provided in its 
synthetic form either as a supplement or through fortification has been previously shown to 
be highly bioavailable (20). Once in the monoglutamate form, folate is absorbed through the 
enterocyte via passive diffusion at high concentrations and through carrier protein encoded 
by the reduced folate carrier (RFC-1) gene in unsaturated, neutral pH conditions (19, 21, 22). 
As the name of the transport protein implies, folate is absorbed in its most reduced THF form 
Figure 2.2: Folate constituents (modified from 16)
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and is transported throughout the body as 5-methyltetrahydrofolate (5-CH3-THF), which is 
primarily attached to albumin (22, 23). Once the 5-CH3-THF reaches its cellular destination, 
the monoglutamate transport form is quickly altered to a polyglutamate form (5-CH3-THFn) 
via the enzyme folypolyglutamate synthase in order to prevent folate from diffusing from the 
cell (23, 24). In the cell, 5-CH3-THFn acts in its coenzymatic role as a one-carbon donor and 
in its unmethylated form, it can act as a one-carbon acceptor to continue methyl group 
metabolism (23).  
Folate and One-Carbon Metabolism  
 The main functions of folate within the cell are as a coenzyme and carrier of one 
carbon groups for both amino acid metabolism, including the regeneration of methionine 
from homocysteine, and nucleotide biosynthesis, such as purine and thymidylate synthesis 
(19). Moreover, the three major cycles requiring folate for one-carbon metabolism is 
comprised of the methionine, purine, and thymidylate cycles (22). Another important 
mechanism that provides additional methyl groups for folate is the interconversion of serine 
to glycine to generate 5,10-methylenetetrahydrofolate (5,10-CH2-THF), an important 
derivative linking the previously mentioned cycles (22, 25). Serine hydroxymethyltransferase 
(SHMT) catalyzes the reversible reaction of serine to glycine, with the vitamin B6 coenzyme 
pyridoxal-pyrophosphate (PLP), and has activity in both the cytoplasm and mitochondria via 
two isozymes (18). This interconversion of the nonessential amino acid serine to glycine may 
provide the most significant portion of methyl groups available to the cell and thus serves as 
an essential reaction to maintain the one-carbon pool (25). 
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 Thymidylate synthesis requires the 5,10-CH2-THF coenzymatic form of folate for the 
irreversible synthesis of deoxythymidine-5-monophosphate (dTMP) from deoxyuirdine-5-
monophosphate (dUMP) by the enzyme thymidylate synthase (TS). dTMP can then be used 
for DNA synthesis and the oxidized folate, dihydrofolate (DHF), can be reactivated to the 
THF form by the enzyme dihydrofolate reductase (DHFR) and remethylated for further one-
carbon reactions. Moreover, 5,10-CH2-THFcan also be oxidized to 10-formyl-THF through a 
series of reactions for purine synthesis for nucleic acid synthesis (26).  
 Although nucleotide biosynthesis requires a significant amount of one-carbon groups 
from folate, methionine synthesis also utilizes a considerable number in the form of methyl 
groups. As a more intricate set of pathways and mechanisms, the methionine cycle involves 
not only a folate dependent remethylation pathway via the most reduced 5-CH3-THF form, it 
also contains a folate-independent remethylation, transsulfuration, and transmethylation 
pathway to carry out various functions in the cell collectively known as methyl group 
metabolism (22, 27). 
Methyl Group Metabolism 
 Methionine plays a central role in methyl group metabolism as it provides the methyl 
group in the activated S-adenosylmethionine (SAM) form for a number of constituents such 
as nucleic acids, lipids, and proteins (28). In order to maintain methyl group homeostasis 
within the cell to exist, sufficient regeneration of methionine from homocysteine, a 
metabolite in methyl group metabolism, and catabolism of homocysteine is vital for normal 
cell functioning. Dietary methionine also plays an important role in providing sufficent 
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substrate for transmethylation reactions in addition to a number of B-vitamins acting as 
coenzymes for both remethylation and transsulfuration reactions (Figure 2.3).  
 Transmethylation 
  As an essential amino acid, methionine participates in reactions collectively termed 
transmethylation through the substrate SAM, which is considered a key methyl group donor 
in nearly all biological reactions within the cell (27, 29). Although transmethylation reactions 
occur in many cells, the liver plays a large role in utilizing SAM in a number of biological 
reactions in addition to its synthesis and degradation (30, 31). Activation of SAM occurs via 
the enzyme methionine adenosyltransferase (MAT) utilizing the adenosyl moiety of 
Homocysteine
Methionine
Cystathionine
Cysteine
SAM
SAH
X
X-CH3
ATP
PPi+Pi
H2O
Adenosine
Serine
H2O
H2O
NH4 + α-Ketobutyrate
Protein
Glutathione
Oxidation
5-CH3- THF
THF
5,10-CH2- THF
Serine
Glycine
Thymidylate &
Purine Synthesis
Choline
Betaine
DMG
MAT
SAH H
MTs (GNMT, PEMT, 
GAMT, DNMT)
CBS (B6)
CGL (B6)
MTHFR(B2)
SHMT (B6)
MS (B12)BHMT
DietProtein Folate
DHF
Transsulfuration
Folate-Independent 
Remethylation
Folate-Dependent 
Remethylation
Transmethylation
Figure 2.3: Folate and one-carbon metabolism  
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adenosine triphosphate (ATP) creating a substrate suitable for methyl group removal (32). 
The group of enzymes collectively called methyltransferases (MTs) remove the methyl group  
from SAM to an acceptor molecule forming S-Adenosylhomocysteine (SAH), which is then 
hydrolyzed to adenosine and homocysteine through the enzyme SAH hydrolase (SAH H), a 
reversible reaction (27, 30). 
 Although there are more than 100 discovered MTs, two of them utilize about 85% of 
methyl groups provided by SAM generating a significant amount of homocysteine in the cell. 
These MTs are phosphatidylethanolamine N-methyltransferase (PEMT) and guanidinoacetate 
N-methyltransferase (GAMT), which catalyze the formation of phosphatidylcholine (PC) 
from phosphatidylethanolamine (PE) and creatine from guanadinoacetate, respectively (31). 
After the synthesis of PC from PE via PEMT, PC can undergo further modification through 
phospholipases to create choline. This enzyme performs the only de novo biosynthesis of 
choline in mammals and utilizes 3 molecules of SAM per molecule of PC making it a large 
consumer of methyl groups (27, 33). 
 GAMT also consumes a significant amount of methyl groups in creatine biosynthesis. 
Guanadinoacetate, the substrate for GAMT, is synthesized by L-arginine-glycine 
amidinotransferase (AGAT), which creates ornithine and guanadinoacetate from arginine and 
glycine. The activity of AGAT occurs primarily in the kidney but the methylation reaction of 
GAMT occurs in the liver again emphasizing the importance of the liver in methylation 
reactions. The final product creatine is then utilized for energy metabolism, specifically in 
muscle and the nervous system (34). There have been discrepancies in the literature 
regarding the major consumer of methyl groups between PEMT and GAMT with one study 
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showing GAMT consuming 75% of available methyl groups with another more recent 
finding that PEMT consumed more than 2 to 3 times that of GAMT (35, 36). Although the 
high rate of methyl group consumption by these two enzymes illustrates an important aspect 
in methyl group metabolism, its influence on homocysteine concentrations may also be 
equally as important (37). 
 Another MT, glycine N-methyltransferase (GNMT), regulates the methyl group 
supply when they are abundant, such as excess dietary methionine, to prevent aberrant 
methylation within the cell. Glycine is the substrate for GNMT and disposes of the methyl 
group as sarcosine (38). However, in times of methyl group deficiencies or rapid cell 
division, such as in cancer, GNMT activity has been shown to be reduced to preserve 
methylation reactions (38, 39). GNMT is primarily expressed in the liver, representing 1-3% 
of the total cytosolic protein, but is also found in other tissues such as the kidney and 
pancreas (40).  A perturbation in GNMT has previously been shown in various disease states 
including diabetes and cancer (40, 41). 
 Folate-Dependent and -Independent Remethylation 
 In the folate-dependent remethylation pathway, the fully reduced and methylated 5-
CH3-THF provides a methyl group to the non-protein forming amino acid homocysteine to 
form methionine (42). The irreversible reduction of 5, 10-CH2-THF to form 5-CH3-THF by 
the enzyme methylenetetrahydrofolate reductase (MTHFR) provides the vitamin B12 
dependent enzyme methionine synthase (MS) with substrate for methyl donation (43). As the 
reaction forming 5-CH3-THF is irreversible, metabolic problems may arise if the substrate 
cannot be utilized within the cell. A vitamin B12 deficiency prevents the transfer of methyl 
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groups to methionine, a disorder that will be discussed in a subsequent section. Upon 
donation of its methyl group to methionine, THF can again acquire a methyl group from a 
donor such as serine for another cycle of remethylation (44). 
 In addition to the folate-dependent pathway, methionine can be derived through a 
folate independent pathway utilizing the enzyme betaine-homocysteine S-methyltransferase 
(BHMT). BHMT removes the methyl group from betaine, or trimethylglycine, to remethylate 
homocysteine and regenerate methionine and create dimethylglycine (DMG) (45). While 
folate-dependent remethylation occurs in all tissues, folate-independent activity is limited to 
kidney and liver tissue (42). Most betaine available to cells comes from the diet, however, the 
nutrient choline can also be oxidized to provide betaine for methyl group metabolism (46). 
Choline is also essential in the diet but can be derived from a methyl group expensive 
transmethylation reaction in the cell, which was discussed previously (45). 
 Transsulfuration  
 The last mechanism in methyl group metabolism utilized to aid in the reduction of 
homocysteine and synthesis of cysteine in the cell is the transsulfuration pathway (47). The 
vitamin B6 dependent enzyme cystathionine beta-synthase (CBS) condenses homocysteine 
with the amino acid serine resulting in cystathionine. Further modification occurs when 
another vitamin B6 dependent enzyme cystathionine γ-lyase (CGL) cleaves cystathionine into 
cysteine and α-ketobutyrate, a non-essential amino acid and key citric acid derivative 
respectively (48). Although cysteine can be acquired through the diet, its de novo synthesis 
can only occur through these set of reactions in animals and enzymatic dysfunction with 
these enzymes may be detrimental to health (47). Likewise, the transsulfuration pathway 
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represents the only catabolic process for the removal of excess methionine and homocysteine 
in the cell and perturbations in enzymatic function could also be damaging to the cell. 
Cysteine, a final product of transsulfuration, can be further utilized in the cell to form 
glutathione, an intracellular redox buffer, in the glutathione synthesis pathway (48). 
Regulation of Methyl Group Metabolism 
 Strict control of methyl group metabolism to limit hyper or hypomethylation of 
cellular proteins, lipids, or nucleic acids is imperative to maintain proper homeostasis within 
the cell. Aberrant methylation may be detrimental to the cell and prolonged perturbed 
methylation patterns may lead to disease. Therefore, allosteric and hormonal regulation of 
enzymes, in addition to nutrient availability, help normalize cellular methyl group 
metabolism. 
 Allosteric Regulation 
 As a significant source of methyl groups, the availability of dietary methionine can 
influence transmethylation in addition to the remethylation of homocysteine within a cell. It 
has previously been shown that in a diet supplying half the basal requirements of methionine, 
the reutilization of homocysteine through remethylation occurred more frequently rather than 
its removal through the catabolic transsulfuration pathway. However, when ample amounts 
of methionine were added to the diet, decreased remethylation and increased catabolism 
occurred (36). Moreover, other studies assessing the influence of methyl donors such as 
choline and betaine during a methionine deficient state show an induction of BHMT mRNA 
to aid in remethylation of homocysteine to sustain methyl group metabolism (49). GNMT is 
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also influenced by dietary methionine and in excess, GNMT activity increases potentially 
limiting methylation in the cell (38).  
 A key component in the allosteric regulation of methyl group metabolism is 
intracellular concentrations of SAM, especially in the liver (50). Moreover, the SAM:SAH 
ratio is an indication of transmethylation potential within the cell and the allosteric control 
associated with this ratio may be perturbed in certain pathologies (28). An important 
regulatory mechanism with a high ratio is the inhibition of MTHFR to prevent the 
irreversible formation of 5-CH3-THF (51) (Figure 2.4). This inhibits the potential for
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Figure 2.4: Allosteric and hormonal control of methyl group metabolism 
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 hypermethylation in the cell by limiting the substrate 5-CH3-THF for remethylating 
homocysteine. In addition, the high SAM:SAH ratio increases the catabolic activity of CBS, 
which decreases the concentration of  homocysteine and thus reduces remethylation to 
methionine (48). BHMT is also regulated by SAM and when concentrations are elevated, 
BHMT is allosterically down-regulated to limit methyl group accumulation within the cell 
(52). 
 Furthermore, control of GNMT within the cell aids in the prevention of increased and 
aberrant methylation. 5-CH3-THF can allosterically inhibit GNMT and when its 
concentrations are decreased with reduced MTHFR activity, GNMT activity increases to 
dispose of excess methyl groups as sarcosine (38, 39). Limiting hypermethylation within the 
cell prevents the downregulation of certain genes in addition to controlling protein activity. 
However, when SAM concentrations decrease and reduce methylation potential within the 
cell, MTHFR activity increases which in turn raises 5-CH3-THF concentrations and 
allosterically prevents GNMT activity. It has also been presented that GNMT activity 
increases in its phosphorylated state and the binding of 5-CH3-THF also prevents 
phosphorylation leading to reduced GNMT activity (53). 
 Hormonal Regulation 
 In addition to allosteric control, hormones have been demonstrated to influence 
methyl group metabolism. With the incorporation of retinoids in the diet, GNMT abundance 
and activity increased, potentially leading to reduced SAM dependent reactions. Moreover, 
increased hepatic GNMT activity from retinoid treatment resulted in the decrease of methyl 
group availability leading to hypomethylation in DNA (54, 55). Glucocorticoids, such as the 
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synthetic cortisol derivative dexamethasone, display similar hormonal regulation as retinoids 
and can increase the activity and abundance of GNMT (56). Furthermore, it has been shown 
with increased glucocorticoid concentrations, such as in times of high stress, MAT is up-
regulated promoting the formation of SAM and increasing methylation potential within the 
cell (57). Additionally, CBS and BHMT are induced by glucocorticoids; however, insulin 
inhibited this induction suggesting its important role in regulating the transsulfuration and 
folate-independent pathways. Also, glucagon was shown to induce CBS promoting increased 
need of glucose precursors for gluconeogenesis provided in the transsulfuration pathway (58-
60). 
 Recent studies have also shown that thyroid hormone plays a critical role in methyl 
group metabolism. In hypothyroidism, a decrease in MTHFR activity was observed, which 
would lead to an increase in GNMT activity from reduced 5-CH3-THF concentrations (61, 
62). Additionally, growth hormone may be important in promoting glutathione degradation, a 
product in the transsulfuration pathway, in addition to down-regulating MAT and GNMT 
activity reducing substrate availability for glutathione production. Reducing glutathione 
concentrations in the cell may decrease cell viability as glutathione aids in reducing oxidant 
damage (63).   
DNA Methylation and Epigenetics 
 As the universal cellular methyl group donor, SAM is a key substrate for DNA 
methylation, an important mechanism in the regulation of gene expression. As all cells of 
multi-cellular organisms contain the same DNA, controlling gene expression is vital for cell 
differentiation and development (64). The term epigenetics means over or above the genome 
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but more specifically, it has been defined as “the study of changes in gene function that are 
mitotically and/or meiotically heritable and that do not entail a change in DNA sequence” 
(65). Perturbations in cellular methylation, such as nutritional deficiencies in methyl-
supplying nutrients like methionine, may aid in the progression of disease (66). 
 Specific sites of DNA methylation occur on the 5’position of cytosine bases creating 
a 5-methyl-cytosine. Mammalian methylation has previously been shown to only occur on 
cytosine residues located next to a guanosine residue, which is called a CpG where the p 
stands for the phosphodiester bond linking the two (64). The regulatory role of methylation at 
CpG sites prevents or promotes the binding of transcription proteins through conformational 
changes in DNA structure. Specifically, a methylated CpG group prevents the binding of 
transcriptional proteins whereas an unmethylated one promotes protein binding (67). 
Previous work has shown that about 5% of all cytosines in DNA are methylated and that 70-
80% of global CpG sites, which are typically located in untranslated intron regions of genes 
and serve as a structural role to the genome, are methylated . The 20% of CpG sites that 
remain unmethylated are called CpG islands and are frequently found in promoter regions of 
genes (66). 
 DNA methyltransferases (DNMTs) are the enzymes responsible for methylating CpG 
sites using SAM as the methyl group donor. There are 4 major DNMTs including DNMT1, 
DNMT2, DNMT3a, and DNMT3b (64). DNMT 1 is responsible for methylating newly 
formed daughter strands of DNA of replicating cells to maintain similar methylation patterns 
of the parent cell (64, 68). Although its name suggests its activity towards DNA, DNMT2 has 
similar physical characteristics of DNMTs but has been shown to methylate RNA instead of 
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DNA (69). DNMT3a and DNMT3b exhibit similar functioning and participate in de novo 
DNA methylation within the cell, specifically unmethylated CpG sites (70). Moreover, 
DNMT3a and DNMT3b assist DNMT1 in proper methylation of the new daughter strands of 
DNA (64). In addition to direct methylation of DNA, proteins associated with DNA, called 
histones, can also be methylated to control gene expression. DNA wraps around histones, 
which compacts DNA and limits the accessibility of transcription machinery (71). 
Methylation of lysine tails located on histones both prevents and promotes transcription by 
closing or opening transcription binding sites, respectively, depending on location and 
number of methyl groups present on the tail (71). Moreover, specific arginine amino acids 
located on histones can also be methylated leading to increased gene expression (71).  
 The supply of methyl groups to DNA via SAM-dependent reactions is directly related 
to the availability of lipotropes within the cell. Deficiencies in lipotrope nutrients, which are 
ones that contain methyl groups like methionine, folate, and choline, may lead to 
perturbations in DNA methylation (72). More specifically, depletion of methyl groups may 
lead to hypomethylated DNA strands increasing the availability of promoter sites for gene 
transcription in addition to reducing DNA integrity leading to potential strand breaks. 
Extensive hypomethylation may be detrimental to the cell by increasing the expression of 
oncogenes promoting the development of cancer (73). Similarly, hypermethylation may 
silence tumor suppressor genes enhancing cancer development. 
Perturbations in Methyl Group Metabolism and Disease 
 From a dietary standpoint, an adequate amino acid and B-vitamin profile are 
imperative for proper methyl group metabolism. Perturbations in dietary intake may 
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influence one-carbon metabolism and contribute to disease development. Moreover, genetic 
polymorphisms and preexisting diseases may also lead to alterations in methyl group 
metabolism independent of dietary status. As with any pathological condition, treatment 
options may be available to prevent and/or limit changes in one-carbon metabolism. 
 Hyperhomocysteinemia 
 The sulfur-containing amino acid homocysteine is created from the demethylation of 
methionine through the transmethylation of SAM (74). Homocysteine is also considered a 
non-protein forming amino acid and high concentrations in the bloodstream, termed 
hyperhomocysteinemia, may be detrimental to health (74, 75). Healthy concentrations of 
homocysteine in the bloodstream are between 5 and 10 micromoles per liter (µmol/L). 
However, hyperhomocysteinemia is categorized as having a concentration greater than 15 
µmol/L, including 15 to 30, 30 to100, and greater than 100 µmol/L for mild, intermediate, 
and severe hyperhomocysteinemia, respectively (76). Elevated homocysteine concentrations 
in the bloodstream can result from perturbations in transsulfuration, remethylation, and 
transmethylation mechanisms (77).  
 The transsulfuration pathway results in the irreversible catabolism of homocysteine 
and deficiencies in CBS activity or vitamin B6 may hinder this mechanism (77). A mutation 
in the CBS enzyme is considered one of the most common causes of hyperhomocysteinemia, 
which may increase disease risk including vascular diseases and mental retardation (47). For 
instance, the 833TÆC allele changes the function of CBS by limiting the binding potential of 
the enzyme to vitamin B6 (78). This also exemplifies the importance of vitamin B6 in the 
catabolism of homocysteine as it is an essential coenzyme for both CBS and CGL activity 
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(79). Moreover, previous studies show that supplementation with vitamin B6 may be 
beneficial in reducing homocysteine concentrations in healthy individuals (80). Along with 
the catabolism of homocysteine, the remethylation reactions also contribute to its reduction. 
 One of the major and most common deficiencies in folate-dependent remethylation of 
homocysteine occurs in the genetic mutation of MTHFR, which catalyzes the irreversible 
reduction of 5,10-CH2-THF to 5-CH3-THF. The most common polymorphism is the cytosine 
to thymine base pair switch that occurs at position 677,  which changes the corresponding 
amino acid from a valine to an alanine (81). This single mutation decreases the stability of 
the enzyme when compared to other alleles (82). Additionally, the occurrence rate of this 
genetic polymorphism occurs in about 12% of the population who are homozygous with the 
T/T mutation whereas the heterozygous mutation C/T occurs in approximately 50% of the 
population (81). Another potential site of altered folate-dependent remethylation occurs with 
the enzyme MS in addition to its coenzyme vitamin B12 or cobalamin.  
 One polymorphism of MS is the conversion of aspartic acid to glycine at the 2756 
base pair from an A to G transformation. This mutation was shown to influence the binding 
of coenzyme B12 and resulting in deficient catalytic activity in the remethylation of 
homocysteine to methionine (83). Furthermore, a lack of vitamin B12 in the cell can also be 
detrimental to the remethylation of homocysteine due to its essential coenzymatic role. As 
the MTHFR reaction is irreversible, the idea of a methylfolate trap occurs as 5-CH3-THF 
accumulates since it can only be utilized through this reaction within the cell (44). Without 
the transfer of a methyl group to methionine, free folate concentrations decrease limiting 
other folate-dependent reactions such as nucleotide biosynthesis (84). Moreover, 
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polyglutamation carried out by the enzyme folypolyglutamate synthase finds 5-CH3-THF as 
a poor substrate and thus the retention of folate within the cell through polyglutamation is 
reduced (84). Furthermore, megaloblastic anemia is a disorder that arises typically from a 
vitamin B12 and/or folate deficiency causing malformation of red blood cells (85). The reason 
for the development of large, immature blood cells seen in megaloblastic anemia is due to 
insufficient substrate for RNA and DNA biosynthesis from inadequate levels in vitamin B12 
and/or folate (86). 
 Reduced transmethylation within the cell can also occur from hyperhomocysteinemia. 
Since the conversion of SAH to homocysteine is a reversible reaction and exists in 
equilibrium, increased concentrations of homocysteine will also increase SAH 
concentrations. This creates an unfavorable situation as SAH acts as an allosteric inhibitor of 
some methyltransferases limiting transmethylation reactions in the cell (87). In addition to 
perturbations in transmethylation from feedback mechanisms of SAH, a reduction in both 
folate-dependent and -independent remethylation of homocysteine may limit methionine 
availability for SAM dependent reactions (42). Moreover, a mutation in GNMT may lead to 
altered methyl group metabolism. As a tetramer, GNMT can exist in a number of different 
conformations and if one subunit acquires a mutation, it may lead to a potentially inactive 
enzyme (88). Since GNMT plays a regulatory role in modulating methyl group metabolism, 
aberrant methylation may occur if the gene becomes defective. 
 Cardiovascular Disease 
 With increased homocysteine concentrations in the bloodstream, the risk of 
developing disease is also elevated. More specifically, hyperhomocysteinemia has been 
20 
 
implicated in cardiovascular disease, such as sudden death, stroke, arterial disease, and 
thromboembolisms (74). Although the literature is fairly controversial regarding the impact 
of hyperhomocysteinemia on the cardiovascular system, a number of case-controlled studies 
have demonstrated that increases in homocysteine concentrations in plasma may increase the 
risk of cardiovascular related events by 2-fold (89). Arguments for the detrimental effects of 
hyperhomocysteinemia on the cardiovascular system are related to the damage of endothelial 
cells caused by oxidative stress and inflammation (90). Moreover, homocysteine was 
observed to exhibit similar properties in endothelial cell damage as hypercholesterolemia and 
hypertension resulting in endothelial dysfunction or limited relaxation of blood vessels (90). 
Oxidation of the vasodilator nitric oxide is one specific proposed mechanism regarding the 
detrimental effects of hyperhomocysteinemia (91). Since homocysteine contains a thiol 
group, it can become oxidized and form reactive oxygen species, which can then cause 
oxidative damage and limit the bioavailability of nitric oxide in the vasculature (92).  
 Neural Tube Defects 
 Along with the concern for cardiovascular disease and elevated homocysteine 
concentrations, neural tube defects (NTDs) have been associated with perturbed methyl 
group metabolism specifically regarding maternal folate status. During embryogenesis, the 
first four weeks are most critical for neurological development and if neurogenesis is 
hindered, the neural tube may not close leading to an NTD (93). Two major forms of NTDs 
are anencephaly, which usually results in a stillborn or in death shortly after delivery, and 
spina bifida, which leads to major disabilities (94). Recent studies have shown that folic acid 
may reduce the incidence of NTDs leading the Centers for Disease Control and Prevention 
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(CDC) to change their standards in food fortification requirements (95, 96). Along with a 
recommendation for women of reproductive age to consume 0.4 mg of folic acid and a 
folate-rich diet in 1992, the CDC made fortification of 140 µg per 100 g of cereal grain 
mandatory in 1998 leading to a 20-30% decrease in the prevalence of NTDs; yet, the current 
fortification requirement has received much scrutiny as it may not be high enough (95-97). 
Genetic variations such as single nucleotide polymorphisms (SNPs), perturbed cellular 
methylation, and folate receptor antibodies are some of the mechanisms explaining the 
importance of folate for the prevention of NTDs. 
 The MTHFR polymorphism, as described previously, leads to reduced cellular folate 
available for remethylation of homocysteine and may impact neurogenesis; however, it is 
still unclear how this polymorphism in the mother influences embryo development (98). 
Autoantibodies, which are immune proteins that target one’s own cells, may also influence 
the availability of folate within the cell. For instance, an autoantibody for the folate-receptor 
membrane protein was discovered in mothers who previously experienced a pregnancy with 
an NTD. Although the mechanism regarding autoantibody formation and activity is not 
specifically known, investigators hypothesize it may contribute to a combination of 
reproductive tissue injury, proteolysis, and genetic mutations leading to the formation of 
autoantibodies against folate receptors (99). Moreover, DNA methylation is thought to 
influence gene expression during embryogenesis and a lack of methyl groups from 
inadequate folate consumption may influence NTD development (93).   
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 Diabetes 
 Another disease known to influence homocysteine and methyl group metabolism is 
diabetes. Currently, a clear relationship between diabetes and changes in homocysteine 
concentrations does not exist; however, recent studies have shown that increases in 
homocysteine may be related to disease progression, such as in cases of nephropathy (29). 
Moreover, a definitive conclusion regarding the influence of homocysteine on insulin 
resistance is inconclusive with reports of positive, negative, and no correlation between the 
two (100-102). In a streptozotocin (STZ) induced type I diabetic rat model, plasma 
homocysteine concentrations were about 40% lower than their control counterparts. 
However, the addition of insulin to this model prevented the drop in homocysteine 
concentrations when compared to the control group. The decrease in homocysteine 
concentrations observed in the type I diabetic rat model may have been due to increased 
transsulfuration enzymes as insulin treatment normalized their activity (58). Also, DNA 
hypomethylation patterns were observed in the same STZ induced rat model suggesting that 
aberrant methylation of DNA in a type I diabetic may lead to altered gene expression (103).  
 In type II diabetes, the change in insulin response during disease progression may be 
related to changes in homocysteine and methyl group metabolism. A typical model used in 
type II diabetic research is the Zucker diabetic fatty (ZDF) rat model, which displays similar 
metabolic perturbations seen in type II diabetes through the development of obesity (104). 
Similarly to type I diabetic rats, type II ZDF rats in an insulin resistant state display 
decreased homocysteine concentrations and increased activity of the CBS and CGL 
transsulfuration enzymes. However, activity of the remethylation enzyme BHMT is also 
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elevated in ZDF rats (105).  Moreover, nephropathy in severe cases of diabetes leads to 
increases in homocysteine concentrations and may be attributed to reduced glomerular 
filtration in the kidneys (106, 107). Also, cardiovascular disease risks are greater in the 
diabetic population and thus maintaining proper homocysteine and methyl group metabolism 
may limit the progression of vascular problems in this population (108).  
 Cancer 
 Perturbations in homocysteine and methyl group metabolism have also been 
implicated in carcinogenesis in addition to the treatment and prevention of cancer. As stated 
previously, folate plays a major role in the formation of dTMP from the precursor dUMP. 
More specifically, 5,10-CH2-THF is the one-carbon donor in this reaction and is considered 
essential for DNA synthesis (109). Thus, a folate deficiency may lead to improper DNA 
synthesis with the loss of thymine for base pairing aiding the development of cancer. 
Moreover, as folate participates in a number of one-carbon reactions, such as methionine and 
purine synthesis, a folate deficiency in addition to perturbed one-carbon enzyme function 
may exhaust folate sources within the cell (109). Furthermore, a deficiency in dTMP 
promotes the incorporation of uracil into DNA leading to double strand breaks, chromosomal 
damage, or genomic alterations leading to carcinogenesis. However, proper folate intake 
limited the incorporation of uracil into DNA in a human population, which may prevent 
mutations in DNA and cancer development (110). Moreover, it has been shown that 
decreased folate intake may negatively influence tumor protein 53 (p53), an important 
protein involved with cell cycle and cell signal regulation during cell growth and division 
(111). A recent report illustrated that the expression and structural integrity of p53 may be 
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influenced by inadequate folate intake potentially leading to the development of neoplasms 
(112). 
 Although adequate folate intake may be beneficial in the prevention of cancer, it may 
also prove to be detrimental in the progression of neoplasms. In the case of a preexisting 
tumor or cancer cell, increased cellular concentrations of folate may promote cancer cell 
development leading to increased proliferation and growth (113). An explanation of this 
disease progression may be due to the significant amount of folate cancerous cells need to 
carry out DNA synthesis (114). Additionally, folic acid fortification of food and 
supplementation with multivitamins may also influence this disease progression as folic acid 
is not the naturally occurring form of the vitamin found in food and is readily absorbable. 
Since folate is converted to its active form through the intestinal wall, poor bioavailability of 
folate may act as a regulatory mechanism to prevent over absorption (114). Therefore, timing 
of supplementation in terms of cancer progression may be a factor when considering dietary 
recommendations.  
 With the notion that folate may contribute to carcinogenesis, antifolates were derived 
in order to disrupt the formation of DNA synthesis through the inhibition of thymidylate and 
purine biosynthesis (115). Specifically, antifolates, such as Methotrexate (MTX) or 
Nolatrexed, have a wide range of action including the inhibition of DHFR or TS, 
respectively. MTX can enter the cell through the same RFC-1 as reduced folates and once 
inside the cell, MTX can bind tightly to DHFR rendering it inactive through competitive 
inhibition. Moreover, MTX is structurally different than folate in that the hydroxyl group 
located on the fourth carbon on the pteridine ring on THF is replaced with an amino group 
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changing substrate binding properties (116) (Figure 2.5). Thus the irreversible binding of 
DHFR to MTX prevents the enzymatic reduction of DHF in the cell by this enzyme, which is 
necessary for purine and thymidylate synthesis. A newer antifolate Nolatrexed inhibits TS 
leading to the reduction of thymidine production from dUMP limiting DNA synthesis (116). 
As polyglutamation and an RFC-1 is required by many antifolates for successful inhibition, 
such as MTX, Nolatrexed doesn’t require either, potentially leading to greater drug 
availability and reduced drug resistance (117).  
 In addition to folate contributing to carcinogenesis, epigenetic changes also influence 
cancer development. For instance, promoter regions of tumor suppressor genes become 
heavily methylated leading to decreased expression of genes vital to cellular functions such 
as cell cycle control and DNA repair (118). However, global DNA hypomethylation occurs 
in many types of breast cancer leading to increased transposable elements, which then insert
 
Figure 2.5: Structural comparison of tetrahydrofolate and Methotrexate (Modified from 116)  
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into other places in the genome mutating other genes (119). Moreover, perturbed histone 
modification also promotes carcinogenesis. Specifically, the loss of acetylation and 
methylation on specific lysine residues of histone H4 may be a significant marker of cancer 
development and may aid in earlier diagnosis (120). Interestingly, using epigenetic 
mechanisms for chemotherapy, such as the reactivation of tumor suppressor genes through 
hypomethylating mechanisms, could potentially be used for cancer treatment (121).  
Impact of Exercise on Methyl Group and Homocysteine Metabolism 
 The benefit of physical activity on human health across the lifespan, especially 
regarding the cardiovascular system, is well established in the literature (12, 13). Although 
the specific mechanism of improved vascular function with exercise is not completely 
understood, changes in arterial stiffness and vascular endothelial cells with physical activity 
may give rise to cardiovascular disease prevention (13). As stated previously, the 
contribution of homocysteine on vascular dysfunction is controversial and has only been 
moderately accepted as an independent risk factor for cardiovascular disease (14). Moreover, 
the influence of exercise on plasma homocysteine concentrations is not well established due 
to significant discrepancies in the literature (122).  
 Two major reasons for the inconsistency in the literature regarding the influence of 
exercise on homocysteine concentrations are the variety of intensities and durations among 
studies. With a single training bout, investigators found an increase, decrease, and no change 
in homocysteine concentrations after exercise when compared to pre-exercise concentrations 
(5, 6, 9). Moreover, the influence of chronic exercise on homocysteine concentrations in 
trained athletes is also inconclusive as studies displayed similar results with increased, 
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decreased, and no differences in concentration (1, 2, 7). Furthermore, the addition of chronic 
exercise training for sedentary individuals was inconsistent resulting in elevated, reduced, 
and no change in homocysteine concentrations (3, 4, 8). The type of exercise and sex of the 
subjects also varied among the previously mentioned studies. Diet records were also not 
consistently controlled for; therefore, intake of pertinent B-vitamins required for methyl 
group metabolism was not accounted for. Moreover, these studies only used the human 
model increasing the error in exercise intensity reporting during testing and diet recall (123).  
 Amino Acid Availability 
 Mechanistically, the influence of physical activity on homocysteine concentrations 
can support both an increase and decrease based on protein and methyl group turnover. With 
exercise, increased methionine catabolism through homocysteine for cysteine synthesis or 
gluconeogenic precursors would lead to a reduction in homocysteine concentrations (123). 
Under conditions of physical exertion, especially during prolonged periods, amino acid 
catabolism increases to fulfill energy requirements for the body  (124). Moreover, the mode 
of exercise may also influence methionine catabolism. For instance, weight lifting women 
had reduced concentrations of methionine in their bloodstream after a single bout of squat 
exercises (125). Also, high protein intake in combination with exercise may also influence 
amino acid availability in the bloodstream (126). A reduction in methionine concentrations 
from poor dietary intake and/or increased catabolism through exercise would promote 
increased methionine synthesis from homocysteine for protein formation assuming the 
individual has proper B-vitamin status for remethylation. Therefore, increased remethylation 
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of homocysteine due to changes in methionine requirements for protein synthesis during 
exercise should reduce homocysteine concentrations (123).  
 In addition to potential homocysteine reducing effects in the plasma through protein 
turnover, B-vitamin status may hinder this process and lead to increased homocysteine 
concentrations. PLP, the active form of vitamin B6, is essential in catabolic reactions 
involving amino acids including homocysteine (123). During exercise, it has been shown that 
PLP levels increase in the bloodstream, potentially increasing the demand for PLP during 
amino acid catabolism in other tissues and its loss through excretion (123, 127, 128). 
Moreover, the decrease in PLP would also reduce the catabolism of homocysteine during 
exercise through the transsulfuration pathway due to its coenzymatic role (79).  
 Increased Transmethylation and Remethylation 
 Another mechanism influencing homocysteine concentrations in the bloodstream is 
the increase in methyl group donation especially during high intensity exercise. A 
transmethylation reaction utilizing as much as 75% of the methyl groups made available by 
SAM is the formation of creatine from guanidinoacetate through the enzyme GAMT (36). 
Creatine is located primarily in muscle and in its phosphorylated form functions by 
rephosphorylating adenosine diphosphate (ADP) to ATP thereby replenishing energy stores 
especially in short high intensity activities. After this transfer, creatine can then be reutilized 
for further reactions involving the rephosphorylation of ADP or excreted through the urine as 
creatinine (129). Thus, mode of exercise may be a significant factor in the formation of 
homocysteine due to increased GAMT activity during high intensity and short duration 
exercises that may rely more on methyl group metabolism than a longer duration and lower 
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intensity exercise (123). Interestingly, supplementation with creatine reduced homocysteine 
concentrations in a rat model suggesting the potential down-regulation of GAMT when 
creatine is present in the cell through feedback mechanisms (130). Another study found that 
subjects, after a bout of exercise, experienced increased endogenous plasma creatine levels 
leading to a decrease in reduced homocysteine, the form present right after synthesis from 
SAH, proposing a potential homocysteine reducing mechanism through feedback inhibition 
from elevated creatine concentrations in the body (131).   
 Choline, an important component in supplying methyl groups in homocysteine and 
methyl group metabolism, may also be influenced by physical activity (132). After 
absorption by the intestine, choline is either phosphorylated to PC or oxidized to betaine in 
cells such as hepatocytes (33). It has previously been shown that in a methyl rich 
environment from a methionine load, supplementing with betaine and PC normalized 
homocysteine concentrations; however, this reduction did not occur with folate 
supplementation (133). Therefore, the folate-independent enzyme BHMT may be utilized 
more readily in times of high methyl group demand in the liver such as during exercise (132). 
Although an increase in BHMT activity might be expected in the liver with exercise, other 
tissues may respond differently. For instance, the expression of BHMT in the colon of rats 
exposed to treadmill exercise was reduced, potentially limiting aberrant methylation, which 
is typically seen in colon cancer, by reducing methyl group supply (134).  
 Perturbed methyl group and homocysteine metabolism is linked to a number of 
diseases and characterizing changes in these mechanisms may give rise to therapies to limit 
or prevent disease progression. Moreover, understanding how exercise influences 
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homocysteine concentrations may be important not only in healthy populations but also ones 
subject to perturbed methyl group metabolism and homocysteine metabolism, such as 
diabetics and individuals with polymorphisms. Therefore, well controlled studies including 
ones with special populations, such as those with the MTHFR polymorphism, are necessary 
to identify the potential benefits of exercise for normalizing one-carbon metabolism. 
Additionally, as specific mechanisms regarding the influence of exercise on the 
cardiovascular system are established, changes in homocysteine metabolism may be a 
contributing pathway in the prevention of cardiovascular disease with regular physical 
activity. Lastly, identifying the most efficient mode and duration of exercise may help tailor 
the recommendation for achieving optimal homocysteine and methyl group metabolism.   
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CHAPTER 3 – EXERCISE PREVENTS HYPERHOMOCYSTEINEMIA 
IN A FOLATE-DEFICIENT MOUSE MODEL 
Abstract 
 Perturbations in homocysteine and methyl group metabolism have been implicated in 
a number of disease states such as cardiovascular disease, cancer, and diabetes. 
Hyperhomocysteinemia occurs with elevated concentrations of homocysteine in the 
bloodstream, and has been indicated as an independent risk factor for progression of 
cardiovascular disease. Removal of homocysteine through remethylation or transsulfuration 
mechanisms is utilized in reducing homocysteine concentrations in the blood. The present 
study examined homocysteine concentrations and pertinent hepatic and renal methyl group 
enzymes in an outbred imprinting control region (ICR) mouse being fed a folate-deficient or 
-sufficient diet. Within each diet treatment, mice were further divided among three groups: 
sedentary, free-access wheel exercise, and forced treadmill exercise. Both treadmill and 
wheel exercised folate-deficient mice displayed greater than 2-fold reduction in 
homocysteine concentrations compared to their sedentary counterpart (p < 0.001). Moreover, 
when control diet mice were considered separately, plasma homocysteine concentrations in 
treadmill and wheel exercised mice were significantly lower than their sedentary counterpart 
(p < 0.05). To our knowledge, this is the first study demonstrating that exercise prevented 
dietary-induced hyperhomocysteinemia in a mouse model. The results from this study may 
serve as a platform for understanding the protective effects of exercise on pathologies 
associated with hyperhomocysteinemia.  
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Introduction 
 Maintaining optimal one-carbon metabolism is essential to promote healthy living. 
Perturbations in these pathways may have significant implications in a number of disease 
states including cancer, cardiovascular disease, neural tube defects, and cognitive disorders 
(135-138). Nutritional status and genetic mutations have profound effects on the interrelated 
mechanisms involving one-carbon metabolism and dietary interventions to maintain optimal 
methyl group, folate, and homocysteine metabolism, such as B-vitamin supplementation, 
may help reduce disease progression (139). Moreover, factors such as supplementation with 
soy isoflavones and increased physical activity are potential modulators of these pathways 
aimed specifically at reducing homocysteine concentrations (140, 141). 
Hyperhomocysteinemia results with the accumulation of homocysteine in the bloodstream 
and has previously been shown to be an independent risk factor for the development of 
cardiovascular disease (142, 143). 
 Homocysteine formation results from methionine metabolism through the 
transmethylation pathway in which the active form of methionine, S-adenosylmethionine 
(SAM), donates a methyl group to a number of acceptor molecules, including proteins, lipids, 
and nucleic acids (28). Homocysteine is then removed via remethylation by folate-dependent 
or -independent mechanisms or irreversibly catabolized through the transsulfuration pathway. 
Folate-dependent remethylation not only relies on the B-vitamin folic acid to provide one-
carbon units for the formation of methionine from homocysteine but also vitamin B12 as a 
coenzyme for methionine synthase (MS), which utilizes the substrate 5-
methyltetrahydrofolate (5-CH3-THF) as a methyl group supply (28). Moreover, folate-
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independent remethylation of homocysteine utilizes the enzyme betaine-homocysteine S-
methyltransferase (BHMT) to transfer a methyl group from betaine to homocysteine (45). 
Irreversible catabolism of homocysteine through the transsulfuration pathway is a vitamin 
B6-dependent reaction through the enzyme cystathionine β-synthase (CBS) which catalyzes 
the eventual formation of cysteine (47).  
 Transmethylation reactions are carried out by more than 100 methyltransferases 
(MTs) with about 85% of methyl groups being utilized by the enzymes 
phosphatidylethanolamine N-methyltransferase (PEMT) and  guanidinoacetate N-
methyltransferase (GAMT) (36, 144). PEMT utilizes three methyl groups from SAM to form 
a phosphatidylcholine (PC) molecule, which generates three homocysteine molecules. It has 
previously been shown in a PEMT knockout model, a lack of PEMT activity significantly 
reduced homocysteine concentrations demonstrating its important role in homocysteine 
production (145). Additionally, supplementation with creatine, the product of the GAMT 
reaction and another large consumer of methyl groups, resulted in a 27% decrease in 
homocysteine concentrations (130). Therefore, creatine supplementation leads to a feedback 
mechanism regulating its formation reducing methyl group consumption and homocysteine 
production (130). 
 Regulation of transmethylation is carried out by the enzyme glycine N-
methyltransferase (GNMT), which is the most abundant methyltransferases in the liver and 
acts to optimize transmethylation reactions within the cell by disposing of excess methyl 
groups as sarcosine (39). Lack of GNMT activity in both a mouse knockout model and 
humans deficient in the enzyme have been previously examined and both models displayed 
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elevations in SAM concentrations and decreases in S-adenosylhomocysteine (SAH), a 
product of transmethylation reactions that is interconvertible with homocysteine based on 
product concentration (146, 147). Therefore, increases in the SAM:SAH ratio may increase 
methylation potential within the cell, which may lead to aberrant methylation of cell 
constituents. However, decreasing the ratio reduces transmethylation activity, potentially 
leading to hypomethylation of cellular components (148). Moreover, increased levels of SAH 
observed in a heterozygous CBS knockout model was directly correlated with increased 
homocysteine concentrations further signifying the importance of homocysteine removal in 
maintaining an optimal SAM:SAH ratio for transmethylation reactions and prevention of 
hyperhomocysteinemia (149).  
 Recently, a number of studies assessing the influence of exercise on homocysteine 
concentrations in humans are fairly ambiguous in regards to acute, chronic, or sedentary 
exercised individuals (1-9). A major issue that contributes to the discrepancies in human 
studies measuring homocysteine concentrations is the inadequacy of monitoring essential B-
vitamins required for homocysteine metabolism in addition to subject training status, 
discrepancies in exercise intensity reporting, and variations in mode, intensity, and duration 
among studies (Husemoen, Thomsen et al. 2004; Joubert and Manore 2006). 
Mechanistically, a reduction in homocysteine concentrations with exercise may be related to 
increased protein turnover. More specifically, it has been measured in both humans and rats 
that methionine concentration in plasma significantly increases during exercise and in 
humans, methionine concentration was shown to decrease below basal levels hours after 
exercise (150-153). This suggests that decreased plasma methionine after an exercise bout 
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may be due in part to increased muscle anabolism requiring methionine thus leading to 
reduced substrate for transmethylation reactions and homocysteine concentration (123, 153). 
On the contrary, exercise increases vitamin B6 demand with increased muscle catabolism and 
excretion which may potentially elevate homocysteine concentrations (128). 
 The present study assessed the influence of both voluntary and involuntary exercise in 
a control and folate-deficient mouse model. The folate-deficient model was used to represent 
a population of individuals with folate absorption deficiencies, reduced folate intake, or 
nucleotide polymorphisms such as in the 5,10- methylenetetrahydrofolate reductase 
(MTHFR) gene, a key enzyme supplying 5-CH3-THF for homocysteine remethylation (81).  
Previously, a folate deficiency has been shown to significantly elevate homocysteine 
concentrations in both human and rodent models and this study aimed at preventing its rise 
with the addition of exercise (10, 11). In the present study, we utilized an exercised folate-
deficient mouse model for measuring both hepatic and renal enzyme function and expression 
involved with homocysteine and methyl group metabolism.  
Experimental Procedures 
Animals and Diets 
 Animal usage and care was carried out in accordance with Iowa State University 
Institutional Animal Care and Use Committee (IACUC). Thirty-two Female Imprinting 
Control Region (ICR) mice (Harlan, Indianapolis, IN) aged 9-10 weeks were initially 
assigned randomly to cages consisting of 2 or 3 in a 12-hour light:dark cycle room and were 
allowed access to food and water ad libitum. Mice were acclimated for 3 days on an AIN-
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93G (Harlan Teklad, Indianapolis, IN) control diet containing 40.2 % cornstarch, 39.3% 
dextrose, 10% casein, 4% mineral mix (AIN-93G-MX), 1% vitamin mix (AIN-93-VX), 5% 
corn oil, 0.2% 1.5 M choline bitartrate, and 0.3% L-methionine.  
 At day 4, mice were divided into the following 3 groups: sedentary (n=11), forced 
treadmill exercised (n=11), or free access wheel exercised (n=10). Wheel exercised mice 
were housed in individual cages in order for accurate distance calculation whereas the 
sedentary or treadmill exercised were housed in groups of 2 or 3. Wheel exercised mice had 
free access to their wheel 24 hours for 5 days a week for the duration of the study whereas 
treadmill exercised mice were forced to run 5 days a week. A final treadmill speed of 16-16.5 
meters per minute for a total of 45 minutes was reached at 28 days, with 18 of those being 
exercise trained, and this speed and duration was used for the remainder of the study. At day 
29, a folate-deficient diet was introduced and mice again were divided within their exercise 
treatment into 6 groups: control diet sedentary (n=5), forced treadmill exercised (n=5), and 
free access wheel exercised (n=5) and a folate-deficient diet sedentary (n=6), forced treadmill 
exercised (n=6), and free access wheel exercised (n=5). 
 On day 77, after 36 days of exercise training with diet treatment, mice were fasted for 
12 hours and given a intraperitoneal injection of fresh ketamine (90 mg/kg body weight) and 
xylazine (10 mg/kg body weight) prior to necropsy. A cardiac puncture was performed with a 
heparinized syringe and whole blood samples were then centrifuged at 4000 x g for 6 
minutes to separate the plasma fraction for homocysteine and glutathione concentration 
determination. Plasma samples were then frozen at -20°C until analysis. Liver tissue was 
collected and 0.5 gram portions were immediately homogenized in a 2 mL ice-cold solution 
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of 10 mM sodium phosphate of pH 7, 1 mM EDTA, 1 mM sodium azide, 0.25 M sucrose, 
and 0.1 M phenylmethylsulfonyl fluoride. Remaining liver tissue was immediately snap 
frozen in liquid nitrogen and stored at -80°C for future RNA analysis. Homogenized tissue 
was then centrifuged at 20,000 x g at 4°C for 30 minutes and the protein layer was removed, 
placed in 1.5 mL Eppendorf tubes, and also stored at -80°C for subsequent enzyme analysis. 
One kidney was homogenized in the same solution utilized for liver tissue in a 1:4 weight to 
volume ratio, centrifuged at 20,000 x g at 4°C for 30 minutes, and the protein isolate stored 
at -80°C for future enzyme analysis. The second kidney was snap frozen in liquid nitrogen 
and also stored at -80°C.  
Determination of Hepatic and Renal Protein Concentrations 
 For protein concentration determination of both liver and kidney homogenates, the 
Pierce Bicinchoninic Acid (BCA) method was used with a protein assay kit (Thermo 
Scientific, Rockford, IL; Pierce Microplate BCA Protein Assay Kit). A standard curve was 
first established using a 2 mg/mL concentration of bovine serum albumin (BSA) on a 96 well 
plate. Each dilution in the BSA standard curve was measured in triplicate with concentrations 
of 2 mg/mL and to 0 mg/mL and a final volume of 17.5 μL in each well. Liver and kidney 
samples were then thawed completely on ice, vortexed thoroughly, and then 2.5 μL of each 
sample was transferred in triplicate to the 96 well plate. Fifteen μL of deionized water was 
then added to the plate to bring the volume to 17.5 μL equaling that of the standard curve. 
One hundred sixty μL of Pierce BCA reagents A and B in a 50:1 ratio, respectively, was 
added to each well and allowed to sit covered for 45 minutes prior to plate reading. 
Absorbance was then read at 562 nm and protein concentrations were analyzed. 
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Determination of Homocysteine and Glutathione Concentrations 
 Total homocysteine and glutathione concentrations were assessed using both High 
Performance Liquid Chromatography (HPLC) and fluorescence detection (154). Blood 
plasma samples were thawed and 100 μL of each sample was diluted with 200 μL deionized 
water for a final volume of 300 μL. 1 mM N-acetylcysteine was added to each sample as an 
internal standard and then incubated for 30 minutes at 4°C in a 10% vol/vol solution of 
tributylphosphine in dimethylformamide. Ice cold 10% trichloroacetic acid with 1 mM 
EDTA was added to stop the reaction and the samples were centrifuged at 4°C for 5 min at 
1000 x g. The supernatant was collected and added to tubes containing 0.125 borate buffer 
with pH 9.5, 0.1% 4-fluoro-7-sulfobenzofurazan, and 1.55 M sodium hydroxide. Before 
injection into the HPLC machine, each sample was filtered using an aerodisc filter (0.22 μm) 
and transferred to new 1.5 mL tubes. Samples were then added (100 μL) into a μBondapak 
C18 Radial-Pak column (Waters) for separation in a mobile phase containing 4% acetonitrile 
and 96% 0.1 M monobasic potassium phosphate buffer (pH 2.1). Chromatograph print outs 
were computer analyzed using the area under the curve method.  
Glycine N-methyltransferase (GNMT) Activity 
 GNMT enzymatic activity was measured based on a previously established method 
with some modifications (155). The reaction mixture (100 μL) contained 2 mM glycine, 200 
mM Tris buffer at pH of 9.0, 0.2 mM S-adenosyl-L-[methyl-3H] methionine, and 5 mM 
dithiothreitol. To initiate the reaction, protein aliquots of 250 μg for each sample were added 
to separate Eppendorf tubes in triplicate with a heat denatured sample serving as a blank. 
After a 30 minute incubation period at 25°C, 50 μL of 10% trichloroacetic acid was added to 
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each Eppendorf tube to stop the reaction. In order to remove excess radiolabeled substrate, 
250 μL of an activated charcoal suspension (78 mg/mL) in 0.1 M acetic acid was added to 
each sample. The samples were then kept at 4°C for at least 20 minutes before centrifugation 
at 4°C for 5 minutes at 13,500 x g. Supernatant aliquots of 200 μL from each sample were 
then added to scintillation vials with 10 ml Scintiverse (Fisher Scientific, Fair Lawn, NJ) for 
radioactivity quantification through liquid scintillation counting. 
Methionine Synthase (MS) Activity 
 Determination of methionine synthase (MS) activity was originally performed by 
Keating and others. (156). AG 1-X8 resin (Cl- form, 100-200 mesh) was used for anion 
exchange. For resin prep, approximately 75 g was washed 3 times with approximately 900 
mL of deionized water in order to clean the resin and remove impurities. The resin was then 
placed in 900 mL of 0.5 M HCl, swirled slightly, and allowed to sit for 90 minutes to prime 
the resin beads. The resin was washed 3 more times in 900 mL of deionized water followed 
by a 900 mL wash with 0.5 M sodium hydroxide. Next, the resin was washed again with 900 
mL 3 times with deionized water followed by another acid wash of 1500 ml 0.5 M HCl. 
After a final rinse with 300 mL of deionized water, the resin was vacuum filtered and washed 
using a Buchner funnel and Whatman filter paper and then stored in deionized water at room 
temperature until use.  
 The reaction mix was prepared with 100 mM DL-homocysteine made fresh before 
use, 1.3 mM cyanocobalamin, 500 mM sodium phosphate buffer of pH 7.5, 10 mM S-
adenosylmethionine, 82.4 mM 2-mercaptoethanol, 1 M dithiothreitol, 15 mM 5-CH3-
tetrahydrofolate, 15 mM 5-[14CH3]-tetrahydrofolate, and deionized water. Hepatic mouse 
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protein (600 μg) was added to eppendorf tubes and a random sample was utilized as a heat 
denatured blank being exposed to 75°C for 10 minutes. Each sample received 100 μL of the 
reaction mix and incubated at 37°C for 1 hour and at the end of incubation, 800 μL of ice-
cold deionized water was added to each sample to stop the reaction. Columns were prepped 
with approximately 1 mL of resin and each sample was added to the column to remove 
excess radiolabeled substrate with the effluent being collected in a scintillation vial. The resin 
was washed twice with 1 mL deionized water and the effluent was again collected in 
scintillation vials. The scintillation vials were then filled with 10 mL of Scintiverse and the 
radiolabeled product was measured using a liquid scintillation counter. 
Betaine Homocysteine S-methyltransferase (BHMT) Activity 
 BHMT activity was previously analyzed and described by Garrow and performed 
with some modifications (157). Resin prep with 100 g of Dowex 1x4 (OH- form, 100-200 
mesh) was washed with 1 L of 2.5 M HCl, stirred, and allowed to settle. The resin was then 
washed twice with 2 L of deionized water and then with 1 L of 500 mM NaOH. A Buchner 
funnel with Whatman filter paper was then used to wash the resin with 2 L of 1 M NaOH and 
a final wash with about 12 L deionized water. The resin was stored at 4°C in a 50% slurry 
with deionized water until use. The reaction mix contained the following: 50 mM [14CH3]-
betaine, 100 mM DL-homocysteine, 500 mM Tris (pH 7.5), 5% BSA, 10% 2-
mercaptoethanol solution, and deionized water. For hepatic tissue samples, 40 μg of protein 
was used and 100 μg was used for renal tissue. Protein samples were added in duplicate to 
the reaction mixture in glass tubes, placed in ice, and covered with rubber stoppers. Samples 
were incubated at 37°C for 1 hour, immediately placed back on ice, and 2.5 mL of ice-cold 
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deionized water was added to stop the reaction. Approximately 1 mL of resin was added to 
each column and the sample was loaded. The column was then washed 3 times with 5 mL of 
water and a final wash with 3 mL of 1.5 M HCl was collected in a scintillation vial. After the 
addition of 10 mL of Scintiverse, radioactivity measurement was done by a liquid 
scintillation counter.  
Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
 RNA was first isolated from 50-100 mg of liver tissue using liquid nitrogen to snap 
freeze the tissue and then homogenized using the mortar and pistol method. The 
homogenized tissue was then transferred to an Eppendorf tube containing 1 mL of Trizol 
(Invitrogen, Carlsbad, CA) and then vortexed and stored in at -80°C overnight to facilitate 
RNA extraction. Samples were then thawed, vortexed, and centrifuged at 12,000 x g for 10 
minutes at 4°C in order to remove unwanted debris. Supernatants were transferred to a new 
Eppendorf tube and allowed to sit at room temperature to dissociate nuclease proteins. A 
molecular grade chloroform wash (200 μL) was added to each tube, vortexed gently, 
incubated at room temperature for 3 minutes, and then centrifuged at 12,000 x g for 15 
minutes at 4°C. The clear supernatant was transferred to a new Eppendorf tube and 500 μL of 
molecular grade isopropyl alcohol was added to precipitate the dissolved RNA, vortexed 
gently, and then incubated at room temperature for 10 minutes before centrifugation at 
12,000 x g for 10 minutes at 4°C. The supernatant was discarded and the RNA pellet was 
washed with 1 mL of 75% molecular grade ethanol in diethylpyrocarbonate (DEPC) treated 
water twice to remove phenol-contaminants. The samples were then centrifuged at 7500 x g 
for 5 min at 4°C with the supernatant removed both times and after the second wash, the 
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samples were allowed to air dry briefly under a hood. RNA was then dissolved in DEPC 
water and incubated at 60°C for 10 minutes. To remove DNA contamination, a Turbo DNA-
free Kit (Ambion, Foster City, CA) was utilized. A 10X Turbo DNase free digestion buffer 
and Turbo DNase I was added to the dilute RNA and incubated for 30 minutes at 37°C. 
DNase Inactivation Reagent was added, gently vortexed, allowed briefly to sit at room 
temperature, and centrifuged for 2 minutes at 10,000 x g. The supernatant was transferred to 
a new eppendorf tube and stored at -80°C until cDNA synthesis.  
 In order to assure RNA purity and sufficient removal of DNA or phenol 
contamination based on absorbance readings, RNA concentrations were assessed with a 
NanoDrop. 2.5 μg of RNA was then added to 0.2 mL Eppendorf tubes with 5X iScript 
reaction mix, Oligo (dt)20 primer, iScript reverse transcriptase (Bio-Rad, Hercules, CA) , and 
DEPC water for reverse transcription to create single stranded DNA or cDNA. Samples were 
then incubated using the following temperature cycle: 5 minutes at 25°C, 30 minutes at 42°C, 
and 5 minutes at 85°C. cDNA was then quantified using a NanoDrop and stored at -20°C 
after synthesis. For Real-time Polymerase Chain Reaction (qRT-PCR), 250 ng of cDNA was 
added in triplicate to a 96 well plate with 10 pmol of forward and reverse primers of a 
specific gene of interest (Table 3.1), IQ SYBR Green Supermix (Bio-Rad, Hercules, CA), 
and DEPC water. The following temperature cycle protocol was then used to amplify the 
target gene (MyIQ, Bio-Rad, Hercules, CA):  3 minutes at 95° C, 40 cycles for 15 seconds at 
95° C, 30 seconds at 60° C, 30 seconds at 72° C, 1 minute at 95° C, and 1 minute at 55° C, 
and 80 cycles for 15 s at 55° C. Analysis of the gene transcripts was done through the 
Comparative CT method utilizing the 18s gene as the loading control gene (158). 
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Statistical Analysis 
 Analysis of the means for each group was conducted by a two-way ANOVA test 
using SigmaStat software (SPSS, Chicago, IL). A significance level of five percent was 
established and when differences of means were found to be significant (p < 0.05), the mean 
values were then compared using Fisher’s least significant difference (LSD) calculation.  
Results 
 Weight reduction reflects exercise training in both folate-deficient and control mice. 
Weight gains in sedentary mice were significantly greater compared to the wheel exercised 
mice and the folate-deficient treadmill exercised but not the control treadmill exercised (p < 
0.05). Initial weights of all mice were not significantly different from one another and there 
wasn’t an influence of diet on weight change (Figure 3.1). 
 Wheel exercised mice ran more total miles compared to treadmill exercised mice. The 
total distance in miles wheel exercised mice achieved during the training period was greater 
than treadmill exercised mice (p < 0.001). Total distance run by both folate-deficient wheel 
exercised and control diet wheel exercised mice were not statistically different from one 
another. Moreover, total distance for treadmill exercised mice did not differ between diet 
treatments.  Average daily distance also did not significantly vary between wheel exercised 
groups (data not shown) (Figure 3.2). 
 Hyperhomocysteinemia was attenuated by exercise in the folate-deficient group. A 
folate deficient diet increased homocysteine concentrations >2 fold when compared to the 
sedentary control group (p < 0.001). Both treadmill and wheel exercise in the folate-deficient 
44 
 
group prevented an increase in homocysteine concentrations exhibited by the folate-deficient 
sedentary group (p < 0.001). When compared to their respective sedentary group, the 
treadmill and wheel exercised animals in the control diet in addition to the wheel exercised 
mice in the folate-deficient diet had reduced homocysteine concentrations when compared to 
the control diet sedentary group (p < 0.05) (Figure 3.3).  
 Glutathione concentrations were not influenced by exercise or diet. Plasma 
glutathione concentrations did not differ among the treadmill exercised, wheel exercised, and 
sedentary mice for both folate-deficient and control diets. Moreover, when dietary treatments 
were considered independent of exercise treatment, glutathione concentrations did not differ 
with the removal of folate. Also, the addition of an exercise treatment independent of diet did 
not significantly influence plasma glutathione concentrations (Figure 3.4). 
 Hepatic GNMT activity was induced by exercise treatment in both dietary groups. 
GNMT activity in the liver for the control wheel and folate-deficient treadmill groups 
increased by 37% and 23%, respectively, when compared to their sedentary counterparts (p < 
0.05). When analyzed alone, the control treadmill (p < 0.05) and wheel exercised mice (p < 
0.001) exhibited 21% and 37 % increased GNMT activity, respectively, compared to the 
sedentary control group. Additionally, the folate-deficient wheel exercised mice displayed 
23% greater GNMT activity when compared to the sedentary control diet group (p < 0.05). 
Moreover, both exercise treatment groups had greater GNMT activity compared to sedentary 
mice when dietary factors were not considered (p < 0.05; data not shown) (Figure 3.5).  
 Liver BHMT activity was elevated in the folate-deficient diet group regardless of 
exercise status. Hepatic BHMT activity increased about 2-fold across all groups in the folate-
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deficient treatment when compared to the sedentary control (p < 0.05). Independent of 
exercise training, BHMT activity was also 70% greater in the folate-deficient group 
collectively when compared to the control group (p < 0.001; data not shown) (Figure 3.6). 
 Free-access wheel running increased renal BHMT activity in both diet groups. Renal 
BHMT activity was 2- and 2.3-fold higher in both control (p < 0.05) and folate deficient (p < 
0.01) wheel exercised mice, respectively, when compared to the sedentary control. 
Additionally, wheel exercised mice had significantly increased kidney BHMT activity 
compared to treadmill exercised when diet was not factored (p < 0.01; data not shown) 
(Figure 3.7). 
 Reduced liver MS activity was measured in both wheel exercised groups. Hepatic MS 
activity was 1.6- and 2.1-fold lower in control (p < 0.05) and folate-deficient (p < 0.001) 
wheel exercised groups, respectively, when compared to the sedentary control diet. Folate-
deficient treadmill mice also displayed 50% less MS activity compared to the sedentary 
control, however, the control treadmill group did not display similar activity (p < 0.05). 
Collectively, both the wheel (p < 0.001) and treadmill (p < 0.05) exercised groups displayed 
1.7- and 1.3-fold reduction in MS activity when compared to the sedentary group 
independent of diet (data not shown) (Figure 3.8). 
 Exercise did not influence hepatic mRNA expression in enzymes of interest. Using the 
comparative Ct method to quantify liver mRNA abundance, only the induction of GNMT in 
the control treadmill group displayed a 1.7 fold increase in mRNA expression (p < 0.05). 
Changes in gene expression of select methyl group metabolism genes were not significantly 
different from the control sedentary group (Table 3.2). 
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Discussion 
 The benefits of regular physical activity for human health have been well established 
in the literature particularly as a means to improve cardiovascular function; however, specific 
beneficial mechanisms are still inconclusive (12, 13, 159). Moreover, hyperhomocysteinemia 
has been previously suggested to be an independent risk factor for cardiovascular disease in a 
number of studies but it is unclear if elevated homocysteine concentrations are a direct cause 
for the disease (160-163). To our knowledge, this is the first study displaying reduced plasma 
homocysteine concentrations in a folate-deficient model previously shown to display 
hyperhomocysteinemia (10, 11). The duration and distance variation between the treadmill 
and wheel exercised groups did not influence changes in homocysteine concentrations 
suggesting that exercise may not be duration- or intensity-dependent; however, some of our 
other measures that influence homocysteine balance do appear to be duration- and intensity-
dependent. Similar results have been observed in human populations where homocysteine 
concentrations were reduced by a variety of exercise modes (5, 7, 8, 140). 
 Mechanistically, enzymatic activity involved with the remethylation of homocysteine 
in the present study does not entirely reflect the observed reduction in homocysteine 
concentrations. A decrease in hepatic MS activity following exercise was evident in both 
control and folate-deficient mice. Based on reduced MS activity, homocysteine 
concentrations should theoretically increase due to decreased remethylation potential. In a 
heterozygous MS deficient mouse, Swanson and colleagues (2001) found that a disruption of 
MS activity lead to an increase in homocysteine concentrations, which conflicts with our 
observations of decreased homocysteine concentrations and reduced MS activity (164). 
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Moreover, Allen and others (1993) found that individuals with a folate-deficiency displayed 
increased dimethylglycine (DMG) and decreased betaine concentrations suggesting an 
increase in hepatic BHMT activity, which coincides with our hepatic BHMT findings in the 
folate-deficient diet group (165). Ohuchi and others (2009) also observed a dietary mediated 
increase in hepatic BHMT activity in addition to reduced homocysteine concentrations in rats 
(166). Thus, our data suggests that increased hepatic BHMT activity contributed to reduced 
homocysteine concentrations in folate-deficient exercised mice. Although hepatic BHMT and 
MS activity were elevated in folate-deficient sedentary animals, homocysteine concentrations 
remained elevated when compared to folate-deficient exercised animals.  
 Homocysteine is a product of all mammalian cells, however, remethylation and 
transsulfuration mechanisms to reduce its concentrations have been shown to be tissue 
specific. For instance, MS activity has been detected throughout most mammalian tissue 
whereas CBS activity occurs primarily in rat and human liver but has also been found in rat 
kidney tissue (167, 168). Moreover, BHMT expression is less distributed in mammalian 
tissue only being detected in rat and human liver and kidney tissue with specific activity in 
rat kidney being significantly less than humans (169, 170). In the present study, renal BHMT 
activity increased in the wheel exercised group suggesting a potential mode or duration effect 
on kidney homocysteine metabolism. With greater BHMT activity prevalent in humans 
compared to rodents, the influence of exercise may be more profound in humans and play a 
more significant role in reducing homocysteine concentrations.  
 As stated previously, the role of GNMT in the cell is to prevent aberrant methylation 
by transferring excess methyl groups to glycine and based on our observations, it may be 
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upregulated with treadmill or wheel exercise (39). Previous studies conducted in our lab have 
also shown that with increased GNMT activity, homocysteine concentrations are 
significantly reduced (56, 171, 172). A potential explanation for the increase in GNMT 
activity may be due to reduced 5-CH3-THF concentrations, which has been previously shown 
to allosterically inhibit GNMT activity (173). The substrate 5-CH3-THF comes from the 
irreversible reduction of 5,10-methylenetetrahydrofolate (5,10-CH2-THF) via the enzyme 
5,10-methylenetetrahydrofolate reductase (MTHFR) (174). 5,10-CH2-THF can also be used 
as a substrate for thymidylate synthase (TS), the enzyme responsible for the formation of 
thymidylate for DNA synthesis (175). Previous work has determined that in exercised mice 
and rats, the concentration of mitochondria and mitochondrial DNA increased in skeletal 
muscle, potentially increasing TS activity for DNA synthesis (176, 177). Therefore, with 
increased need of thymidylate for DNA synthesis during exercise, TS may compete with 
MTHFR reducing 5,10-CH2-THF availability for folate-dependent remethylation and 
therefore reduce the allosteric inhibition of GNMT (178).  
 Remethylation patterns in the liver, the primary site for amino acid metabolism, did 
not coincide with the reduction in homocysteine concentrations observed in exercised mice 
for this study (179). Other mechanisms to reduce homocysteine may have been more 
prominent with exercise treatment, such as decreased methionine substrate availability for 
transmethylation. Dohm and colleagues (1981) observed an increase in methionine 
concentrations in rat plasma, muscle, and liver immediately following treadmill running or 
forced swimming and proposed this increase was due to elevated muscle catabolism for 
energy expenditure (152). Others have also shown similar increases in plasma methionine 
49 
 
concentrations during cycle ergometer training but also displayed a significant reduction in 
the hours post-exercise suggesting in increase in protein synthesis and thus limiting the 
availability of methionine for transmethylation (150, 151, 153). Reductions in methionine 
availability in the bloodstream during various modes of exercise may have important 
implications for dietary methionine requirements to support both muscle and methyl group 
metabolism. 
 The irreversible transsulfuration of homocysteine provides cysteine for a number of 
products, such as glutathione, and α-ketobutyrate which can be metabolized to CO2  (42, 77). 
As an antioxidant in the body, glutathione has been shown to exist primarily in its oxidized 
form during exercise as a response to increased oxidative stress (180). Moreover, Sastre and 
others found similar oxidation effects of glutathione during exercise but 1 hour after exercise, 
resting levels of reduced glutathione were measured and total concentrations of glutathione 
were unchanged (181). Although initial total glutathione was not analyzed in the present 
study, similar results were observed as there was no difference in glutathione concentrations 
between the sedentary and exercised groups. As glutathione is not the only fate of cysteine 
through the transsulfuration pathway, this measurement cannot solely refute that catabolism 
of homocysteine is not perturbed with the addition of exercise. Future studies need to assess 
CBS abundance and activity in order to establish the influence of exercise on the 
transsulfuration of homocysteine. 
 From the present study, it was evident that exercise normalized homocysteine 
concentrations in a mouse model known to experience hyperhomocysteinemia. Although 
liver enzymatic remethylation mechanisms did not completely reflect the observed changes 
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in homocysteine, renal enzymatic activity corresponded to changes in homocysteine 
concentrations potentially establishing an important role of kidney homocysteine metabolism 
during exercise. Future research will need to establish the connection between the 
transsulfuration pathway and exercise in regulating homocysteine metabolism in addition to 
the activity changes of pertinent transmethylation enzymes, such as PEMT and GAMT, to 
understand how normal cellular methylation patterns might be perturbed with exercise. 
Additionally, understanding the influence of frequency, mode, duration, and intensity on 
homocysteine concentrations may help to determine a potential dose response. Furthermore, 
understanding the impact exercise has on populations with known perturbations in methyl 
group and homocysteine metabolism, such as diabetics, vegans, and individuals with genetic 
polymorphisms, may serve as an aid in normalizing these mechanisms.  
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Genes Forward Primers Sequences Reverse Primers Sequences
GNMT TTG AAG AAG CCA ACT GGT TGA CGC TGC AAT GTT CTT TAG TGC CAG CCG
MS ATG GCA CAG GAG GGA AGA AAG TCA TGC CCT TCA CAA GAG CAT ACT CCA
BHMT AGT TCG TCA GCT TCA TCG GGA GTT AAG CAG CTT CGT TGA CTT TCT GCC
CBS TCA CAT TCT GGA CCA GTA CCG CAA ACT TCT CCT TCA GCT TTC TGG CGA
PEMT TAT GAT GAG CCA GCC CAA GAT GGA GAA GCT GGA CAG CAC AAA CAC GAA
18s  (Ribosomal RNA) TCA TGC AGA ACC CAC GAC AGT ACA TGT TGT CTA GAC CGT TGG CCA GAA
Table 3.1: Forward and reverse primer sequences for folate, methyl-group, and homocysteine metabolism enzymes 
(Real-time PCR; Integrated DNA Technologies).      
 
 
T
ables and Figures 
 
 
 
 
Table 3.2: Hepatic mRNA mean fold induction relative to sedentary control diet group. Data are represented as means ± S.E.            
(n = 4-6). Values followed by * are statistically different from the sedentary control diet group (p < 0.05). 
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Gene
Fold 
Induction p-value
Fold 
Induction p-value
Fold 
Induction p-value
Fold 
Induction p-value
Fold 
Induction p-value
GNMT 1.26 ± 0.27 0.473 1.71  ± 0.22 0.049* 0.71 ± 0.10 0.205 1.67 ± 0.31 0.113 1.02 ± 0.12 0.937
BHMT 1.06 ± 0.35 0.913 1.42 ± 0.32 0.422 0.54 ± 0.12 0.241 1.78 ± 0.50 0.244 1.15 ± 0.26 0.749
CBS 1.07 ± 0.31 0.878 1.06 ± 0.31 0.903 0.51 ± 0.06 0.116 1.30 ± 0.43 0.578 0.78 ± 0.12 0.526
MS 1.53 ± 0.79 0.514 1.16 ± 0.38 0.756 0.81 ± 0.12 0.548 1.04 ± 0.22
 
0.920 0.72 ± 0.13 0.427
PEMT 1.13 ± 0.22 0.590 0.98 ± 0.12 0.923 0.91 ± 0.08 0.471 1.11 ± 0.15 0.558 0.85 ± 0.06 0.238
Sedentary Treadmill
Folate Deficient Diet
Wheel
Control Diet
Treadmill Wheel Sedentary
1.00 ± 0.22
1.00 ± 0.38
1.00 ± 0.30
1.00 ± 0.31
1.00 ± 0.10
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Figure 3.1: Initial weight of mice prior to exercise treatment and final weight of mice before 
euthanasia for control and folate-deficient diet sedentary, treadmill exercised, and wheel 
exercised treatment groups. Data are expressed as means ± S.E (n= 4-6). Bars denoted with 
different letters are statistically different within the group (p < 0.05). 
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Figure 3.2: Total distance run by control and folate-deficient diet treadmill and wheel 
exercised mice. Data are expressed at means ± S.E. (n = 5).  
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 Figure 3.3: Homocysteine concentrations for control and folate-deficient diet sedentary, 
treadmill exercised, and wheel exercised mice. Data are expressed as means ± S.E. (n = 4-6). 
Bars labeled with different letters are significantly different (p < 0.001). Bars labeled with an 
* are statistically lower than the control diet sedentary group (p < 0.05).  
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Figure 3.4: Glutathione concentrations for control and folate-deficient diet sedentary, 
treadmill exercised, and wheel exercised mice. Data are represented as means ± S.E. (n = 4-
6).  
Control Diet
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Figure 3.5: Glycine N-methyltransferase (GNMT) activity for control and folate-deficient 
diet sedentary, treadmill exercised, and wheel exercised mice. Data are expressed as means ± 
S.E. (n = 4-6). Bars not followed by the same letter are statistically different (p < 0.05). Bars 
represented by an * are significantly greater than the sedentary control diet group (p < 0.05).
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Figure 3.6: Hepatic betaine-homocysteine S-methyltransferase (BHMT) activity for control 
and folate-deficient diet sedentary, treadmill exercised, and wheel exercised mice. Data are 
represented as means ± S.E. (n = 4-6). Bars not denoted by the same letter are significantly 
different (p < 0.05).   
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Figure 3.7: Renal betaine-homocysteine S-methyltransferase (BHMT) activity for control 
and folate-deficient diet sedentary, treadmill exercised, and wheel exercised mice. Data are 
represented as means ± S.E. (n = 4-6). Bars not labeled with the same letters are statistically 
different (p < 0.05).  
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Figure 3.8: Methionine Synthase (MS) activity for control and folate-deficient diet 
sedentary, treadmill exercised, and wheel exercised mice. Data are represented as means ± 
S.E. (n = 3-6). Bars not represented by the same letter are statistically different (p < 0.05). 
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CHAPTER 4 – GENERAL CONCLUSIONS 
 Proper methyl group and homocysteine metabolism is imperative for human health as 
evident by the number of pathologies associated with disturbances in these pathways 
including diabetes, cancer, and cardiovascular disease (40, 143, 182). A number of 
mechanisms have been put forth to modulate perturbed methyl group and homocysteine 
metabolism such as B-vitamin supplementation to enhance homocysteine reduction and the 
use of antifolates in limiting cancer progression (116, 183). Although fairly controversial in 
the human population, the present study demonstrated the potential benefits of exercise by 
reducing and normalizing homocysteine concentrations in a folate-sufficient and -deficient 
mouse model, respectively. Utilizing this model helped to limit high variability seen in a 
number of human studies including uncontrolled dietary intake, differences in subject 
training status, and mode of exercise tests (123, 184, 185). Moreover, this model allowed us 
to collect hepatic and renal tissue, a significant limitation in the human population for a 
thorough assessment of homocysteine and methyl group metabolism.  
 It is well established that exercise promotes cardiovascular health as demonstrated in 
both human and rodent models but the protective mechanisms are still fairly controversial 
(12, 13, 159, 186). Moreover, the elevation in homocysteine concentrations has been 
implicated as an independent risk factor for cardiovascular disease although the current 
mechanism regarding the influence of homocysteine on the cardiovascular system is still 
unknown (160-163). Taken together, the homocysteine lowering effects shown in this study 
for both a folate-deficient and -sufficient mouse model may potentially explain one 
protective mechanism of exercise in cardiovascular health. Future research will need to 
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examine vascular integrity and function in order to establish a direct correlation between the 
two.  
 Consistent with previous research in our lab and others, the present study clearly 
demonstrated the significant influence a dietary limitation such as folate restriction has on 
homocysteine concentrations (10, 11, 40). As a folate deficiency with concomitant 
hyperhomocysteinemia has been specifically linked to disorders such as coronary heart 
disease and Alzheimer’s, exercise may play an important role in reducing the incidence of 
these pathologies (187, 188). Although homocysteine concentrations in folate-deficient mice 
were normalized with exercise, other cellular processes, like de novo thymidylate synthesis, 
absolutely require folate (19). Therefore, exercise should only be viewed as a potential 
modulator of homocysteine concentrations typically seen in folate deficiencies and not as a 
dietary replacement. Moreover, this model serves as a platform for other populations prone to 
hyperhomocysteinemia independent of folate such as individuals with genetic 
polymorphisms and vegans. 
 The enzymatic changes observed with exercise in both folate-deficient and -sufficient 
models did not offer major insight into the reduction of homocysteine concentrations as the 
sedentary groups displayed similar or elevated remethylation patterns, as seen with hepatic 
betaine homocysteine S-methyltransferase (BHMT) and methionine synthase (MS) activity, 
respectively. However, renal enzymatic function may become more important for reducing 
homocysteine concentrations with exercise due to increased BHMT activity observed in 
wheel exercised mice. Moreover, a decrease in methionine availability is one proposed 
mechanism in the reduction of homocysteine with exercise. It has previously been shown that 
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amino acid availability fluctuates during and after exercise due to changes in energy 
requirements and protein metabolism (150-153). Specifically, the enhanced protein synthesis 
seen post exercise would then warrant the observed decrease in plasma methionine. Future 
studies will need to assess changes in methionine concentrations to see the extent of 
incorporation into proteins during exercise in addition to its availability for transmethylation 
reactions within cells. Moreover, previous work has demonstrated a significant increase in 
homocysteine concentrations with methionine loading (189). Thus, examining the influence 
exercise has on homocysteine concentrations with methionine loading may offer some 
insight into methionine use during exercise. 
 Another aspect of methyl group and homocysteine metabolism that requires more 
investigation is the transsulfuration pathway. Although changes in glutathione, a major 
product of transsulfuration, were not different among the sedentary and exercise treatments, 
enzymatic function in addition to other metabolites of transsulfuration may have been 
influenced by exercise. For instance, cysteine, the precursor for glutathione production, has 
previously been shown to decrease significantly in exercised rat plasma indicating a potential 
increase in the oxidation of cysteine for energy or utilization in protein synthesis (190). Thus, 
cystathionine beta-synthase (CBS) and cystathionine γ-lyase (CGL) abundance and activity 
should be measured to understand the role of transsulfuration in homocysteine metabolism 
during exercise.  
  Although this study further emphasizes the importance of exercise in disease 
prevention, it also provides potential insight into homocysteine management in populations 
with diabetes, genetic polymorphisms, and diet restrictions that experience 
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hyperhomocysteinemia. Therefore, exercise may be an additional mean of combating 
pathologies associated with hyperhomocysteinemia in these populations where dietary or 
medical intervention is limited, such as in individuals with the methylenetetrahydrofolate 
reductase (MTHFR) polymorphism. Likewise, dietary choices of vegans limit essential B-
vitamin consumption, specifically vitamin B12, and exercise could potentially mediate the 
elevation in homocysteine concentrations experienced with perturbed homocysteine 
remethylation. However, exercise may also be important in controlling homocysteine 
concentrations in normal populations as a preventative mechanism in limiting the 
development of disease.  Future research should be aimed at understanding the influence of 
exercise on methyl group and homocysteine metabolism in regards to mode, frequency, and 
intensity across all populations. 
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